AstraZeneca is a company that makes bio-carrier solution for humanize antibody that has been used in the drug delivery process in human physiological system. The manager is considering adding a nonmetal-based nanoparticle (Type C or Si) to its solution to increase the product performance at medium temperatures. The costs associated with each type are estimated. If the company's MARR is 15% per year then:

AstraZeneca is a company that makes bio-carrier solution for humanized antibody that has been used in the drug delivery process in human physiological system. The manager is considering adding a nonmetal-based nanoparticle (Type C or Si) to its solution to increase the product performance at medium temperatures. The costs associated with each type are estimated. If the company's MARR is 15 % per year, Then: Initial cost, $ Annual cost, $/yr Salvage value, $ Life, years Type C 150,000 -92,000 30,000 Type Si -280,000 -74,000 70,000 4 a) Draw cash flow diagram for cost estimates for Type C and Type Si b) What is the LCM & Si), d) Which nanoparticle type should the company select for each method (LCM and Study Period)? Give reasons for your choice